Lansdowne Partners

AMNIS Treasury Services AG is a Zurich-based company founded in 2014 that specializes in providing an online platform for currency transactions. The firm caters primarily to small and medium-sized enterprises, offering a suite of services that includes international payments, treasury management, currency exchange, and risk management. AMNIS aims to reduce costs associated with international transactions and streamline financial operations for its clients. Its platform features local payment capabilities in several regions, including Switzerland, the UK, the US, and the EU, as well as tools for managing team expenditures. Additionally, AMNIS offers multi-currency debit cards and 24/7 currency exchange services at transparent rates, along with interest-bearing safeguarded accounts in multiple currencies.

Nattergal is a nature restoration company that specializes in large-scale environmental investment. Its primary focus is to drive global biodiversity recovery by strategically investing in the restoration of degraded terrestrial and marine ecosystems. The company aims to deliver significant societal benefits and sustainable financial returns through its focused approach to rewilding.

G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.

Oxford Quantum Circuits is a developer of advanced quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company focuses on creating unique superconducting circuits essential for quantum computation, ensuring high-quality qubit control and maintaining operational efficiency. Their quantum computers are fully integrated units, comprising the necessary control systems, hardware, and software, which enable customers to enhance their operations, innovate new methodologies, and tackle pressing issues. Through its pioneering technology, Oxford Quantum Circuits contributes to groundbreaking advancements that hold the potential for transformative impacts across various industries.

TechMet Limited is a private industrial company based in Dublin, Ireland, established in 2017. It focuses on securing the supply of key technology metals essential for advanced technologies, including electric vehicles, renewable energy systems, and energy storage devices. The company engages in various stages of the metal supply chain, encompassing mining, processing, refining, and recycling. TechMet's portfolio includes interests in production and development assets located in Africa, North America, and South America. By addressing supply chain challenges associated with critical metals such as nickel, cobalt, lithium, rare earth metals, vanadium, tungsten, and tin, TechMet aims to ensure a stable and sustainable supply that supports the growing demand from emerging technologies.

Crux Asset Management is an asset management firm that offers a range of investment services to clients in Asia, Europe, and the United Kingdom. The company is dedicated to delivering superior investment returns and exceptional client service through a team of highly experienced professionals. Crux specializes in managing long-only equity investments and provides opportunity funds, allowing clients to capitalize on growth potential. By focusing on both the management of its business and the funds it oversees, Crux Asset Management aims to meet the diverse needs of its clientele while fostering robust earnings.

Tungsten West plc is a mining company focused on the Hemerdon tungsten and tin mine located near Plymouth in Devon, England. With a compliant Mineral Resource of approximately 325 million tonnes at a grade of 0.12 percent WO3, the company aims to capitalize on the growing demand for strategic metals, particularly tungsten and tin, which are essential for modern technology. Tungsten West plans to restart production at Hemerdon within the next 12 months, leveraging existing infrastructure to achieve low-cost operations. The company's strategic focus is to effectively meet the increasing market demand for these critical materials.

Oxford Ionics is a quantum computing startup focused on developing high-performance quantum computers through the use of trapped-ion technology. The company combines advanced qubit designs with a noiseless electronic control system, allowing for accurate and reliable manipulation of qubits. This technology enables the parallel control of interconnected qubit registers, ensuring performance is not compromised. By employing standard semiconductor fabrication methods, Oxford Ionics aims to create scalable quantum chips that enhance computational capabilities for complex problem-solving. The company's innovations position it to significantly advance the quantum computing market, providing clients with dependable solutions for high-performance applications.

Osler Diagnostics is a UK-based company focused on providing accessible and accurate health diagnostics. Founded in 2017 as a spin-off from the University of Oxford, the company has leveraged extensive research in portable diagnostic technologies, originally stemming from the development of the blood glucose sensor. Its flagship product, the Osler Origin, is a portable laboratory capable of delivering lab-quality diagnostics anytime and anywhere, enabling individuals to conduct tests for a variety of health biomarkers using just a drop of blood. This innovative approach aims to decentralize healthcare, making it easier for users to monitor their health and make informed decisions, ultimately supporting healthier and longer lives. Osler Diagnostics is headquartered in Oxford, UK, and aims to serve all major healthcare settings globally.

Replay is a genome writing company focused on advancing genomic medicine by reprogramming biological systems through the synthesis and delivery of large DNA constructs. The company aims to harness the potential of genome engineering to create innovative solutions in medicine, enhancing the ability to manipulate genetic material for therapeutic purposes. By developing technologies that enable precise DNA writing, Replay seeks to redefine the landscape of genetic research and its applications, ultimately contributing to improved health outcomes and the treatment of various diseases.

Circ, founded in 2011 and based in Danville, Virginia, operates a textile recycling business. It focuses on transforming discarded clothing into valuable raw materials for fabric production. Circ's proprietary technology enables it to cost-effectively recycle various fiber types, including cotton, poly-cotton, polyester, and nylon, using water as a solvent. The company aims to meet consumer demands for sustainability without compromising quality, price, or convenience. It produces market-grade dissolving pulp and petroleum monomers equivalent to virgin materials, which can be sold at competitive prices to manufacturers.

Oxford Quantum Circuits is a developer of advanced quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company focuses on creating unique superconducting circuits essential for quantum computation, ensuring high-quality qubit control and maintaining operational efficiency. Their quantum computers are fully integrated units, comprising the necessary control systems, hardware, and software, which enable customers to enhance their operations, innovate new methodologies, and tackle pressing issues. Through its pioneering technology, Oxford Quantum Circuits contributes to groundbreaking advancements that hold the potential for transformative impacts across various industries.

AMNIS Treasury Services AG is a Zurich-based company founded in 2014 that specializes in providing an online platform for currency transactions. The firm caters primarily to small and medium-sized enterprises, offering a suite of services that includes international payments, treasury management, currency exchange, and risk management. AMNIS aims to reduce costs associated with international transactions and streamline financial operations for its clients. Its platform features local payment capabilities in several regions, including Switzerland, the UK, the US, and the EU, as well as tools for managing team expenditures. Additionally, AMNIS offers multi-currency debit cards and 24/7 currency exchange services at transparent rates, along with interest-bearing safeguarded accounts in multiple currencies.

OXECO is a chemistry technology firm focused on creating, engineering, and manufacturing specialty chemicals specifically for the clean technology and transportation industries. The company utilizes advanced carbene technology to power its ONTOTM technology platform, which influences surface behavior. OXECO provides a range of services, including surface treatment chemicals, practical surface treatments, chemical insertions, and the development of hydrophobic and hydrophilic coatings. This portfolio enables clients to effectively control and modify surface characteristics, enhancing the performance of materials in their applications.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.

Verve Events is a prominent player in the live entertainment industry, specializing in word-of-mouth sales. The company leverages networks of advocates to promote and sell events and experiences, incentivizing these advocates with rewards such as free tickets and backstage passes. Trusted by more than 500 events globally across over 40 countries, Verve effectively enhances event visibility and attendance through its unique marketing approach. The company collaborates with major ticketing platforms like Ticketmaster, Eventbrite, Paylogic, and Front Gate Tickets to streamline the sales process and enhance customer engagement.

Papier Limited, founded in London in 2015, specializes in designing and printing customized cards and stationery, including wedding invitations, birthday cards, notebooks, and planners. The company's offerings encompass a wide range of occasion-specific products, such as seasonal cards and photo-related items. With a focus on quality materials and artful design, Papier aims to encourage meaningful connections among individuals in an age dominated by digital communication. By providing beautifully crafted stationery items, Papier enhances the experience of giving and receiving personal messages, standing out from other online card and invitation platforms. Additionally, the company operates digital printing studios to support its production needs.

FINABRO GmbH, founded in 2016 and based in Vienna, Austria, specializes in online financial advisory services focused on personal savings and investments. The company provides a web-based platform that assists customers in managing their savings and investments effectively. Through its mobile application, FINABRO offers personalized savings plans, allowing users to allocate their funds into various pension plans that promise higher returns with reduced risk. By emphasizing active and professional risk management, FINABRO aims to simplify the investment process for individuals, addressing the challenges of low-interest savings accounts and the complexities of alternative investment options.

Ribbon Biolabs GmbH is a Vienna, Austria-based company founded in 2018 that specializes in the synthesis of long DNA molecules. The company aims to advance molecular biology by developing innovative methods for DNA synthesis, enabling the creation and exploration of genetic solutions through high-throughput synthesis of unprecedentedly long DNA sequences. Ribbon Biolabs' technology supports a wide range of applications, including genome construction, high-throughput libraries, DNA-based data storage and computing, and the development of DNA nanotechnologies. This allows researchers and companies to work with extensive DNA libraries without economic or time constraints.

Depixus is a biotechnology company that focuses on advanced genomic analysis through its innovative technology designed for real-time examination of biomolecular interactions. By enabling comprehensive analysis across full genomic regions, the company provides a platform that allows researchers to customize the level of sequencing and epigenetic detail required. This capability facilitates the exploration of new biological pathways, the understanding of disease mechanisms, and the development of precision medicines. Depixus aims to overcome the limitations of current sequencing technologies, which struggle to capture dynamic molecular interactions with single-molecule precision, thus enhancing the ability to unlock valuable insights in genomic research.

The Raspberry Pi Foundation is a prominent organization focused on designing and developing high-performance, low-cost single-board computers and compute modules. These products cater to a diverse range of markets, including industrial IoT, education, and hobbyist applications. Known for its credit-card sized computer that connects to televisions and keyboards, Raspberry Pi enables users to perform various tasks, from word processing to playing high-definition video. The foundation operates as a full-stack engineering entity, engaging in extensive research and development efforts either in-house or through strategic partnerships. Its capabilities encompass the entire value chain, from developing semiconductor intellectual property to the design of finished electronic products and software engineering, ensuring a comprehensive approach to meeting the needs of its customers.

Hellsicht develops AI technology solutions for the defence and security sector.

TechMet Limited is a private industrial company based in Dublin, Ireland, established in 2017. It focuses on securing the supply of key technology metals essential for advanced technologies, including electric vehicles, renewable energy systems, and energy storage devices. The company engages in various stages of the metal supply chain, encompassing mining, processing, refining, and recycling. TechMet's portfolio includes interests in production and development assets located in Africa, North America, and South America. By addressing supply chain challenges associated with critical metals such as nickel, cobalt, lithium, rare earth metals, vanadium, tungsten, and tin, TechMet aims to ensure a stable and sustainable supply that supports the growing demand from emerging technologies.

Genomics PLC is a company based in Oxford, United Kingdom, specializing in algorithms and software solutions that focus on cancer, microbes, and rare diseases. Founded in 2014, it aims to revolutionize healthcare through advanced analyses of extensive genomic and phenotypic datasets. By leveraging its expertise, the company provides healthcare providers and governments with tools to enhance patient diagnoses and treatment options. Additionally, Genomics assists pharmaceutical and biotechnology firms in mitigating risks during the drug development process by providing insights into genomic data. Its analytical platform facilitates the investigation of genomic sequences, helping to identify individuals at risk of various diseases. Through these innovations, Genomics seeks to set standards in the use of genomic data, ultimately aiming to improve healthcare outcomes and advance human biology understanding.

Genomics PLC is a company based in Oxford, United Kingdom, specializing in algorithms and software solutions that focus on cancer, microbes, and rare diseases. Founded in 2014, it aims to revolutionize healthcare through advanced analyses of extensive genomic and phenotypic datasets. By leveraging its expertise, the company provides healthcare providers and governments with tools to enhance patient diagnoses and treatment options. Additionally, Genomics assists pharmaceutical and biotechnology firms in mitigating risks during the drug development process by providing insights into genomic data. Its analytical platform facilitates the investigation of genomic sequences, helping to identify individuals at risk of various diseases. Through these innovations, Genomics seeks to set standards in the use of genomic data, ultimately aiming to improve healthcare outcomes and advance human biology understanding.

Genomics PLC is a company based in Oxford, United Kingdom, specializing in algorithms and software solutions that focus on cancer, microbes, and rare diseases. Founded in 2014, it aims to revolutionize healthcare through advanced analyses of extensive genomic and phenotypic datasets. By leveraging its expertise, the company provides healthcare providers and governments with tools to enhance patient diagnoses and treatment options. Additionally, Genomics assists pharmaceutical and biotechnology firms in mitigating risks during the drug development process by providing insights into genomic data. Its analytical platform facilitates the investigation of genomic sequences, helping to identify individuals at risk of various diseases. Through these innovations, Genomics seeks to set standards in the use of genomic data, ultimately aiming to improve healthcare outcomes and advance human biology understanding.

Cambridge Innovation Capital, established in 2013, is a venture capital firm based in Cambridge, UK. It specializes in early-stage investments, focusing on life sciences and technology companies with affiliations to the University of Cambridge or the Cambridge Cluster. The firm invests in a wide range of sectors, including healthcare, therapeutics, medtech, digital health, genomics, and emerging technologies such as AI, IoT, and quantum technologies. Cambridge Innovation Capital typically invests up to £19 million per company, providing long-term equity finance to support the growth and commercial development of innovative businesses. As a preferred investor for the University of Cambridge, the firm has access to a robust pipeline of investment opportunities within the ecosystem. Since its inception, Cambridge Innovation Capital has raised £275 million to fund disruptive, deep-tech businesses.

Drayson Technologies Limited is an Internet of Things (IoT) platform company that specializes in wireless charging technology and machine learning software to develop smart sensor networks. Founded in 2015 and based in London, the company offers a diverse portfolio of solutions aimed at improving environmental monitoring and health management. Key products include CleanSpace, an air pollution monitoring platform for enterprises and municipalities; CleanSpace API, which integrates air quality data into software applications; Aura, which monitors indoor assets and environmental conditions; SEND, designed for vital sign monitoring in hospital patients; GDm-health, a diabetes management system for pregnant women; and EDGE, which focuses on managing chronic obstructive pulmonary disease. Drayson Technologies also operates sales hubs in Mexico and San Francisco, California, emphasizing energy-efficient and cost-effective IoT data collection and analysis.

BenevolentAI is a clinical-stage company specializing in AI-enabled drug discovery and development. By leveraging its advanced AI platform alongside scientific expertise and laboratory capabilities, the company aims to create novel drug candidates that demonstrate a higher likelihood of clinical success compared to traditional approaches. The Benevolent Platform supports a robust pipeline that includes over 20 drug programs, encompassing all stages from target discovery to clinical studies. Additionally, BenevolentAI collaborates with major pharmaceutical companies and leading research and charitable institutions to enhance its research efforts. The company is headquartered in London, with research facilities in Cambridge and an office in New York.

Spotify, headquartered in Stockholm, Sweden, is a global music streaming service provider. As of 2023, it has 602 million monthly active users. The company offers on-demand access to songs across various devices, enabling users to search, discover, and share music. It also provides artists with tools to share their work and promote their careers. Spotify generates revenue through a paid subscription model, known as Spotify Premium, and an ad-supported service. In 2023, these models contributed to 86% and 14% of its total revenue, respectively.

Genomics PLC is a company based in Oxford, United Kingdom, specializing in algorithms and software solutions that focus on cancer, microbes, and rare diseases. Founded in 2014, it aims to revolutionize healthcare through advanced analyses of extensive genomic and phenotypic datasets. By leveraging its expertise, the company provides healthcare providers and governments with tools to enhance patient diagnoses and treatment options. Additionally, Genomics assists pharmaceutical and biotechnology firms in mitigating risks during the drug development process by providing insights into genomic data. Its analytical platform facilitates the investigation of genomic sequences, helping to identify individuals at risk of various diseases. Through these innovations, Genomics seeks to set standards in the use of genomic data, ultimately aiming to improve healthcare outcomes and advance human biology understanding.

ACHICA is a members-only luxury lifestyle store based in Cheltenham, United Kingdom. Founded in February 2010 by online retail experts Quentin Griffiths and William Cooper, the company provides its members with access to exclusive discounts of up to 70% on a variety of luxury products, including homeware, garden items, clothing, gifts, and lifestyle accessories. The store operates on a private sale model, featuring new brands every day for limited periods of 48 hours, ensuring that only its members can access these offers. This approach protects the brands promoted on the platform and maintains exclusivity, as the site is closed to search engines and price comparison sites. Membership is free, allowing a broad audience to take advantage of the luxury items available through ACHICA.

Aldermore Bank is a UK-based commercial bank established in 2009, specializing in providing straightforward financial products and services primarily to small and medium-sized enterprises (SMEs), homeowners, landlords, and individual clients. The bank focuses on four main lending areas: asset finance, invoice finance, SME commercial mortgages, and residential mortgages. It serves a diverse range of sectors, including automotive, logistics, media, construction, and manufacturing, among others. By offering tailored financial solutions, Aldermore Bank aims to meet the specific needs of its clients, thereby facilitating their growth and financial stability.

Displaydata Ltd. specializes in the design and supply of fully graphic electronic shelf labels (ESLs) and dynamic digital display solutions tailored for omni-channel retailers. Founded in 2000 and based in Bracknell, United Kingdom, with a support center in Atlanta, the company offers a range of products, including the Chroma and Aura ESLs that utilize electrophoretic display technology. Their solutions facilitate secure, two-way data communication between headquarters and retail locations, allowing for real-time updates of product information and pricing. Key offerings include Dynamic Communicator, Dynamic Central, and Dynamic Console, which manage and monitor ESLs across multiple stores. Additionally, Dynamic Capture interfaces with existing retail data to enhance pricing accuracy, while Dynamic Connect and Dynamic Create provide further customization and connectivity options. Displaydata has established partnerships with major retail brands globally, helping them optimize revenue and enhance the customer experience at the shelf-edge.

Infinity SDC is a distinguished UK data centre operator with a portfolio of strategically located facilities near London. The company specializes in designing, building, and maintaining highly efficient data centre environments that cater to a diverse clientele, including investment banks, cloud vendors, systems integrators, and telecommunications companies. Infinity SDC focuses on providing resilient, flexible, and secure infrastructure, while also assisting clients in reducing their energy costs and carbon footprints. The company offers a comprehensive range of premium data centre services, from shared data halls to fully bespoke, client-dedicated solutions, all aimed at exceeding customer expectations both commercially and technically.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.